Revenue
2024
2025
| 2025 | 2024 | |
|---|---|---|
| Revenue | $13.6M | $11.8M |
| Gross profit | $7.2M | $6.4M |
| Research & development | $18.3M | $15.1M |
| Operating expenses | $32.7M | $26.3M |
| Operating income | −$25.5M | −$19.9M |
| EBITDAderived | −$25.3M | −$19.7M |
| Net income | −$25.3M | −$19.9M |
| Basic EPSper diluted share | -$1.03 | -$9.85 |
| Diluted EPSper diluted share | -$1.03 | -$9.85 |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 3, 2025Form 4/A | Tsai Chen LungDirector | BuyCommon Stock | 20 | $4.17 | $83.40 | 20 |